Ignite Creation Date:
2025-12-24 @ 9:39 PM
Ignite Modification Date:
2026-01-03 @ 5:31 AM
Study NCT ID:
NCT02625532
Status:
UNKNOWN
Last Update Posted:
2018-08-29
First Post:
2015-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D006379', 'term': 'Helping Behavior'}], 'ancestors': [{'id': 'D012919', 'term': 'Social Behavior'}, {'id': 'D001519', 'term': 'Behavior'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D005498', 'term': 'Follicular Phase'}, {'id': 'D008183', 'term': 'Luteal Phase'}], 'ancestors': [{'id': 'D008597', 'term': 'Menstrual Cycle'}, {'id': 'D055703', 'term': 'Reproductive Physiological Phenomena'}, {'id': 'D012101', 'term': 'Reproductive and Urinary Physiological Phenomena'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 60}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2015-12', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-08', 'completionDateStruct': {'date': '2019-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2018-08-27', 'studyFirstSubmitDate': '2015-11-09', 'studyFirstSubmitQcDate': '2015-12-06', 'lastUpdatePostDateStruct': {'date': '2018-08-29', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2015-12-09', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2018-10', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'number of oocytes in metaphase II obtained', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'number of oocytes in metaphase II obtained by follicular puncture'}], 'secondaryOutcomes': [{'measure': 'number of oocytes cumulus complexes', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'number of oocytes cumulus complexes obtained by follicular puncture'}, {'measure': 'duration of stimulation (days)', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'number of days from the start of ovarian stimulation until the day of follicular puncture'}, {'measure': 'cycle cancellation rate', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'ratio of canceled cycles regarding the number of ovarian stimulation cycles initiated'}, {'measure': 'Luteinizing hormone levels following administration of agonist for final oocyte maturation', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'Luteinizing hormone blood levels the day after administration of agonist for final oocyte maturation'}, {'measure': 'occurrence of side effects', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'occurrence of side effects at the end of study'}, {'measure': 'fertilization rate', 'timeFrame': 'Through study completion, average 2 weeks', 'description': 'Number of correct fertilization oocytes 18 hours post-insemination'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Controlled Ovarian stimulation', 'Follicular phase', 'Luteal phase', 'Reproductive Techniques, Assisted'], 'conditions': ['Reproductive Techniques, Assisted']}, 'referencesModule': {'references': [{'pmid': '32033610', 'type': 'DERIVED', 'citation': 'Llacer J, Moliner B, Luque L, Bernabeu A, Lledo B, Castillo JC, Guerrero J, Ten J, Bernabeu R. Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial. Reprod Biol Endocrinol. 2020 Feb 7;18(1):9. doi: 10.1186/s12958-020-00570-7.'}]}, 'descriptionModule': {'briefSummary': 'Exploratory, prospective, randomized, comparative, open trial with control group treated to assess the efficacy of follicular phase ovarian stimulation compared to lutheal phase ovarian stimulation in women with Bologna criteria for poor ovarian response.', 'detailedDescription': 'Two arms is established, the study group that will start ovarian stimulation in the luteal phase and the control group that will start ovarian stimulation in the follicular phase.\n\nThe randomization will be made in the 2-3 day of the menstrual cycle, according to a list of random allocation of treatments. After check that there is no contraindication to start the stimulation, the patients will be assigned to the treatment group.\n\nThe patients in the control group (follicular phase group) will start stimulation with two vials of 150 IU recombinant FSH + 75 IU recombinant LH (Pergoveris® 150/75). The patients in the study group (luteal phase group) will perform daily urine LH test from day 7th of the cycle and will start the administration of 150 IU recombinant FSH + 75 IU recombinant LH (Pergoveris® 150/75) at two vials daily from the 4th day of the LH positive test.\n\nAntagonist cetrorelix acetate (Cetrotide® ) administration will start when the largest follicle shall be equal or greater than 14 mm. From this moment controls every 24-72 hours with foliculometría by ultrasound and blood hormone analysis with determination of estradiol and progesterone. For the final oocyte maturation 2 vials daily of 0.2 mg triptorelin acetate (Decapeptyl®) is administered. Oocyte collection will be made by transvaginal ultrasound-guided puncture according to IB protocol\n\nThe dosages and protocols used will be the usual for patients with diagnostic of poor ovarian response.'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT'], 'maximumAge': '40 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Patient Bologna meets the criteria to be diagnosed as low responder\n* Age under 41 years\n* Regular menstrual cycles between 21 and 35 days\n* Indication of in vitro fertilization\n* Indication of start stimulation with 300 IU of FSH\n* Presence of both ovaries\n* Ability to participate and comply with the study protocol\n* Having signed the written consent form\n\nExclusion Criteria:\n\n* Presence of follicles larger than 10 mm in the randomization visit\n* Endometriosis III / IV\n* Concomitant uterine pathology: adenomyosis, submucosal myomas, Asherman's syndrome...\n* Concurrent participation in another study"}, 'identificationModule': {'nctId': 'NCT02625532', 'acronym': 'LUTEAL', 'briefTitle': 'Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)', 'organization': {'class': 'OTHER', 'fullName': 'Instituto Bernabeu'}, 'officialTitle': 'Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles: A Randomized Comparative Single Center Trial. LUTEAL Trial', 'orgStudyIdInfo': {'id': 'BER-LUT-2015-02'}, 'secondaryIdInfos': [{'id': '2015-003856-31', 'type': 'EUDRACT_NUMBER'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Follicular phase', 'description': 'Controlled ovarian stimulation starts during follicular phase on day 2-3 of the menstrual cycle', 'interventionNames': ['Procedure: Follicular phase']}, {'type': 'EXPERIMENTAL', 'label': 'Luteal phase', 'description': 'Controlled ovarian stimulation starts during luteal phase on day 3 to 5 after first LH positive urine test', 'interventionNames': ['Procedure: Luteal phase']}], 'interventions': [{'name': 'Follicular phase', 'type': 'PROCEDURE', 'otherNames': ['Ovarian stimulation starts during the follicular phase'], 'description': 'Controlled ovarian stimulation starts on day 2-3 of the menstrual cycle with recombinant recombinant FSH + LH, adding cetrorelix when the follicles reach 14 mm size and ovarian maturation with triptorelin acetate', 'armGroupLabels': ['Follicular phase']}, {'name': 'Luteal phase', 'type': 'PROCEDURE', 'otherNames': ['Ovarian stimulation starts during the luteal phase'], 'description': 'Controlled ovarian stimulation is started between 3rd and 5th day after the first LH positive urine test, adding cetrorelix when follicles reached 14 mm size and ovarian maturation with triptorelin acetate', 'armGroupLabels': ['Luteal phase']}]}, 'contactsLocationsModule': {'locations': [{'zip': '03016', 'city': 'Alicante', 'country': 'Spain', 'facility': 'Instituto Bernabeu', 'geoPoint': {'lat': 38.34517, 'lon': -0.48149}}], 'overallOfficials': [{'name': 'Joaquín Llácer', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Instituto Bernabeu'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Instituto Bernabeu', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Gynaecologist. Reproductive Medicine Specialist at Instituto Bernabeu', 'investigatorFullName': 'Joaquín Llácer', 'investigatorAffiliation': 'Instituto Bernabeu'}}}}